Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro.
Research Article
The Versatile Mutational Resistome of Pseudomonas aeruginosa.
Review
gyrA
Epidemiology and antimicrobial resistance of pathogens in pediatric sinus infections: a retrospective study at a Japanese otolaryngology clinic (2023-2025).
Research Article
Mutations in gyrA were associated with reduced susceptibility to levofloxacin in H. influenzae isolates.
A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
Research Article
The presence of Asp82Gly or Gly81Asp alone led to low-level resistance to fluoroquinolones but not to nalidixic acid resistance. When both mutations were present, resistance to both nalidixic acid and fluoroquinolones was expressed.
Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Research Article
Mutations in the quinolone resistance-determining region (QRDR) of gyrA were associated with resistance to quinolones.
Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in Elizabethkingia anophelis.
Research Article
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
Research Article
G81D mutation confers resistance to ciprofloxacin only. If G81D and D82G are present simultaneously, there is also nalidixic acid resistance
Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Research Article
G81D mutation confers resistance to ciprofloxacin only. If G81D and D82G are present simultaneously, there is also nalidixic acid resistance
gyrA
The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity.
Research Article
Burkholderia dolosa gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3004860
gyrA
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.
Review
gyrA
No comments yet. Be the first to comment!